AFYX Therapeutics
AFYX Therapeutics is a specialty pharmaceutical company that repurposes existing technologies to address unmet medical needs, a strategy it calls Reversed Innovation. The company develops products such as low-dose oral misoprostol tablets for the induction of labour and nimorazole for hypoxic modification in head and neck cancer patients. Its target market includes healthcare providers in Europe, Northern Ireland, and Sub-Saharan Africa.
Biopharmaceutical
Healthcare
Pharmaceuticals
Funding summary
- Total raised
- €11.2M
- Funding rounds
- 1
Investors in AFYX Therapeutics
Investors on record for AFYX Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like AFYX Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors